GT Biopharma, Inc. (GTBP) › Total LiabilitiesGT Biopharma, Inc. (GTBP) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2010: $5.65M2011: $5.23M2012: $6.56M2013: $6.48M2014: $30.46M2015: $50.62M2016: $18.95M2017: $2.68M2018: $14.03M2019: $19.71M2021: $10.26M2022: $5.00M2023: $6.63M2025: $1.32M$1.32M2010Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$1.32M—2023$6.63M+32.6%2022$5.00M-51.2%2021$10.26M—2019$19.71M+40.5%2018$14.03M+423.7%2017$2.68M-85.9%2016$18.95M-62.6%2015$50.62M+66.2%2014$30.46M+370.0%2013$6.48M-1.2%2012$6.56M+25.5%2011$5.23M-7.5%2010$5.65M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share